BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Amazon
AMZN
|
+$839M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$331M |
| 3 |
Visa
V
|
+$314M |
| 4 |
Apple
AAPL
|
+$297M |
| 5 |
Broadcom
AVGO
|
+$287M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$595M |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$362M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$250M |
| 4 |
DuPont de Nemours
DD
|
+$208M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$198M |
Sector Composition
| 1 | Technology | 23.99% |
| 2 | Consumer Discretionary | 11.98% |
| 3 | Healthcare | 10.54% |
| 4 | Financials | 9.96% |
| 5 | Industrials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
SPDR S&P Pharmaceuticals ETF
XPH
$184M
| $2.36M | ﹤0.01% |
56,658
+51,561
| +1,012% | +$2.15M |
|
1252
AMN Healthcare
AMN
$699M
| $2.36M | ﹤0.01% |
31,476
-22,252
| -41% | -$1.67M |
|
1253
Portland General Electric
POR
$4.66B
| $2.35M | ﹤0.01% |
54,182
-15,670
| -22% | -$679K |
|
1254
Lantheus
LNTH
$3.6B
| $2.35M | ﹤0.01% |
37,838
-96,334
| -72% | -$5.97M |
|
1255
First Trust NASDAQ Cybersecurity ETF
CIBR
$10.8B
| $2.34M | ﹤0.01% |
43,467
+2,610
| +6% | +$141K |
|
1256
Bilibili
BILI
$10.5B
| $2.32M | ﹤0.01% |
190,752
-90,983
| -32% | -$1.11M |
|
1257
Evolus
EOLS
$465M
| $2.32M | ﹤0.01% |
220,399
+127,541
| +137% | +$1.34M |
|
1258
Innospec
IOSP
$2.05B
| $2.32M | ﹤0.01% |
18,826
-3,091
| -14% | -$381K |
|
1259
iShares MSCI Hong Kong ETF
EWH
$737M
| $2.32M | ﹤0.01% |
133,450
-574,702
| -81% | -$9.98M |
|
1260
Haemonetics
HAE
$2.51B
| $2.32M | ﹤0.01% |
27,097
-6,485
| -19% | -$555K |
|
1261
Ingredion
INGR
$8.09B
| $2.31M | ﹤0.01% |
21,242
+13,499
| +174% | +$1.47M |
|
1262
iShares Floating Rate Bond ETF
FLOT
$9.07B
| $2.3M | ﹤0.01% |
45,502
-64,498
| -59% | -$3.26M |
|
1263
Grand Canyon Education
LOPE
$5.89B
| $2.3M | ﹤0.01% |
17,435
+12,353
| +243% | +$1.63M |
|
1264
Snowflake
SNOW
$74.9B
| $2.3M | ﹤0.01% |
+11,560
| New | +$2.3M |
|
1265
Corcept Therapeutics
CORT
$7.68B
| $2.3M | ﹤0.01% |
70,777
-20,768
| -23% | -$675K |
|
1266
COPT Defense Properties
CDP
$3.46B
| $2.29M | ﹤0.01% |
89,528
+21,786
| +32% | +$558K |
|
1267
Moelis & Co
MC
$5.54B
| $2.29M | ﹤0.01% |
40,794
-11,744
| -22% | -$659K |
|
1268
Tidewater
TDW
$2.93B
| $2.27M | ﹤0.01% |
31,510
-15,710
| -33% | -$1.13M |
|
1269
Vanguard FTSE All-World ex-US ETF
VEU
$49.7B
| $2.27M | ﹤0.01% |
40,396
-246,554
| -86% | -$13.8M |
|
1270
California Water Service
CWT
$2.76B
| $2.26M | ﹤0.01% |
43,646
-3,857
| -8% | -$200K |
|
1271
Rayonier
RYN
$4.05B
| $2.26M | ﹤0.01% |
71,042
+61,809
| +669% | +$1.96M |
|
1272
WEX
WEX
$5.82B
| $2.26M | ﹤0.01% |
11,604
-15,892
| -58% | -$3.09M |
|
1273
Cheesecake Factory
CAKE
$2.82B
| $2.26M | ﹤0.01% |
64,455
-9,077
| -12% | -$318K |
|
1274
Materion
MTRN
$2.31B
| $2.25M | ﹤0.01% |
17,297
-2,357
| -12% | -$307K |
|
1275
NovoCure
NVCR
$1.36B
| $2.25M | ﹤0.01% |
150,414
-22,127
| -13% | -$330K |
|